Publicaciones en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (16)

2023

  1. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 20, pp. 18161-18171

  2. Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.

    European Journal of Internal Medicine, Vol. 110, pp. 54-61

2022

  1. Antibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 5, pp. 225-228

  2. Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 10, pp. 471-473

2021

  1. A Bayesian Model to Predict COVID-19 Severity in Children

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 8, pp. E287-E293

  2. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2099-2106

  3. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 9, pp. e397-e401

  4. Pain and Achilles tendon shortening in patients with idiopathic toe walking

    Revista de Neurologia, Vol. 73, Núm. 9, pp. 307-314

  5. QuantiFERON-TB Gold Plus Assay Specificity in Children and Adolescents With Suspected Tuberculosis - A Multicenter Cross-sectional Study in Spain

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 9, pp. E348-E351

2020

  1. Diagnostic Accuracy of QuantiFERON-TB Gold Plus Assays in Children and Adolescents with Tuberculosis Disease

    Journal of Pediatrics, Vol. 223, pp. 212-215.e1

2019

  1. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364

2018

  1. Characterizing normal and pathological gait through permutation entropy

    Entropy, Vol. 20, Núm. 1

  2. Gait phenotypes in paediatric hereditary spastic paraplegia revealed by dynamic time warping analysis and random forests

    PLoS ONE, Vol. 13, Núm. 3

2016

  1. Urine metabolome profiling of immune-mediated inflammatory diseases

    BMC Medicine, Vol. 14, Núm. 1

2014

  1. PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis

    Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769

2012

  1. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes

    Human Molecular Genetics, Vol. 21, Núm. 20, pp. 4549-4557